Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Identifying inherited susceptibility to colorectal cancer in high-risk Ashkenazi Jewish individuals

FY 2017-18

Summary
Colorectal cancer is the second leading cause of mortality related to cancer worldwide. It typically results from genetic alterations in cells of the colon that transform into polyps with abnormal growth capabilities, which then develop into malignant tumours. Some individuals have a higher risk of developing colorectal cancer due to family history and genetic background. The Ashkenazi Jewish (AJ) population is one of the most genetically isolated populations; it carries important genetic mutations in multiple colorectal cancer susceptibility genes that are seen more frequently in this population than the ones typically observed in the general population. Recent studies identified novel genes that predispose to colorectal cancer when they are mutated, but no mutations have been identified in these genes in the AJ population yet. The goal of this project is to use high throughput sequencing technologies to identify mutations predisposing to colorectal cancer in these novel genes in a large group of affected AJ individuals. My results will contribute to improved genetic testing, reducing unnecessary interventions in individuals at lower risk. The identification of mutations predisposing to cancer provides patients with a measure of control over their disease and inform their own health-related decision-making, thus improving their psychological well-being. This project will not only improve our understanding of cancer inheritance in affected patients, but will also help identify novel biomarkers for screening, diagnosis and treatment of at-risk patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386556
Name
Geoffrion Dominique
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying inherited susceptibility to colorectal cancer in high-risk Ashkenazi Jewish individuals
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ashkenazi Jewish Germ-Line Mutations; Colorectal Cancer; Familial Adenomatous Polyposis; Genetic Predisposition; Hereditary Polyposis
Abstract
Colorectal cancer is the second leading cause of mortality related to cancer worldwide. It typically results from genetic alterations in cells of the colon that transform into polyps with abnormal growth capabilities, which then develop into malignant tumours. Some individuals have a higher risk of developing colorectal cancer due to family history and genetic background. The Ashkenazi Jewish (AJ) population is one of the most genetically isolated populations; it carries important genetic mutations in multiple colorectal cancer susceptibility genes that are seen more frequently in this population than the ones typically observed in the general population. Recent studies identified novel genes that predispose to colorectal cancer when they are mutated, but no mutations have been identified in these genes in the AJ population yet. The goal of this project is to use high throughput sequencing technologies to identify mutations predisposing to colorectal cancer in these novel genes in a large group of affected AJ individuals. My results will contribute to improved genetic testing, reducing unnecessary interventions in individuals at lower risk. The identification of mutations predisposing to cancer provides patients with a measure of control over their disease and inform their own health-related decision-making, thus improving their psychological well-being. This project will not only improve our understanding of cancer inheritance in affected patients, but will also help identify novel biomarkers for screening, diagnosis and treatment of at-risk patients.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Geoffrion, Dominique
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~